The signalling cascades related to PPARγ are potential therapeutic targets to promote osteoblast differentiation in osteoporosis and age-related osteopenia and therapeutic methods that act through suppression of PPARγ or inhibition of its ligand synthesis have been proposed [3, 18]. The gene discussed is PPARG; the disease is Osteopenia.